Suzanne Ildstad, Director at Talaris Therapeutics, Inc. (TALS), sold 31,531 shares at $2.56 ($80K) on 2023-06-01, disclosed to the SEC on 2023-06-05.
Open-market sale of $80k TALS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.56 | 15,713 | $40K | 50.4% |
| 2 | $2.50 | 15,818 | $40K | 49.6% |
| Total | $2.53 avg | 31,531 | $80K | 100% |
| Filing → |
| TALS | SELL | 2023-06-07 | $149K | — | Filing → |
| TALS | SELL | 2023-04-25 | $35K | — | Filing → |
| TALS | SELL | 2023-04-21 | $266K | — | Filing → |